Margie L. Traylor - 15 May 2023 Form 4 Insider Report for Augmedix, Inc.

Role
Director
Signature
/s/ Margie L. Traylor
Issuer symbol
N/A
Transactions as of
15 May 2023
Net transactions value
+$22,400
Form type
4
Filing time
17 May 2023, 19:00:21 UTC
Previous filing
21 Jun 2022
Next filing
16 Jun 2023
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction AUGX Common Stock Options Exercise $22,400 +10,182 +96% $2.20 20,801 15 May 2023 Direct

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction AUGX Stock Option (Right to Buy) Options Exercise $0 -10,182 -100% $0.000000* 0 15 May 2023 Common Stock 10,182 $2.20 Direct F1, F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 This transaction reflects a cash exercise of a stock option, awarded under the Augmedix, Inc. 2020 Equity Incentive Plan, without a subsequent sale of the underlying shares of common stock.
F2 Fully vested.